Pharm-Olam

Recent Milestones in Rare Cancer Research

Cancer research has evolved exponentially over the last two centuries. The first time…

8 Strategies for Navigating Clinical Studies During COVID-19 | Pharm-Olam

COVID-19 has presented a…

Risk Management: Foundation for Better Project Management | Pharm-Olam

What is the Difference Between Microbiome and Microbiota?

Understanding the Connection Between COVID-19 and VAP

Importance of Natural History Study to Rare Disease Drug Development

5 Key Considerations Non-EU Based Sponsors must have for GDPR Compliance in Clinical Trials

Understanding the 3 Types of Clinical Trial Monitoring

Completing a Rescue Study Transition — How Much Time Do You Need?